2023 Review: Innovation-driven, Continued Growth
In the past year, Singclean Medical has adhered to the development philosophy of innovation as its core and continued to promote technological progress in the field of medical devices. A series of products such as injectable cross-linking, medical sodium hyaluronate, absorbable hemostatic products, and in vitro detection reagents have achieved significant market share. Singclean Medical's market position has steadily improved, contributing to the progress of the medical industry and the well-being of patients.
In terms of product research, Singclean Medical has been committed to leading technological innovation in the industry, and through continuous investment in research and development, the products under development include: Skformula Sodium Hyaluronate Dressing, Singmeso Light Crosslinked Sodium Hyaluronate Solution for Mesotherapy, Singone Cross-linked Sodium Hyaluronate For Intra -Articular Single Injection, Surgiclean® Absorbable Collagen Hemostotic Sponge, etc., thereby improving the patient's treatment effect and quality of life.
In terms of sales promotion, Singclean Medical has increased the market penetration of its products by establishing a global sales network and strengthening close cooperation with partners. Singclean Medical's products are now sold in more than 120 countries and regions around the world, such as Italy, Germany, Turkey, Thailand, Brazil, and Chile.
2024 Plan: Comprehensive Upgrade, Global Leadership
Facing 2024, Singclean Medical actively responds to industry development trends and formulates a comprehensively upgraded development strategy to further consolidate its leading position in the field of medical devices.
In terms of product research, Singclean Medical will continue to increase investment in research and development and promote the development of new generation medical device products. In particular, Singclean Medical plans to strengthen cooperation with scientific research institutions and medical experts, and use global wisdom to provide more innovative and safe medical solutions.
In terms of sales promotion, Singclean Medical will actively expand into emerging markets while deeply exploring existing markets. Through digital marketing methods, we will enhance brand awareness, expand our partner network, and help our products serve patients around the world more broadly.
In terms of employees, Singclean Medical will strengthen internal training programs to improve the professional level of employees and cultivate more industry professionals. Singclean Medical believes that having an innovative and professional team is an important guarantee for achieving Singclean Medical's long-term development goals. We will continue to pay attention to employees' work-life balance, provide a more competitive salary and benefit system, and add more employee care projects to create a more pleasant working environment for employees.
Through unremitting efforts, Singclean Medical is committed to becoming a global leader in the field of medical devices, providing more advanced and reliable medical products and services to patients around the world. In the new year, Singclean Medical looks forward to working with its partners to create brilliance and contribute more to the development of the medical industry.
-
singclean | 2024-01-08
Singclean’s Medical Sodium Hyaluronate Gel for Bone Joint Gained EU MDR CE Certification, Ranking Among First 3 Globally! 协合医疗骨科医用透明质酸钠凝胶成功斩获欧盟MDR CE认证!跻身全球前三!This achievement sets multiple industry records: it is the first MDR CE certificate for hyaluronic acid-based orthopedic products ever issued by DNV worldwide. Singclean Medical has become the first Chinese company to obtain such certification in this category and has successfully ranked among the first 3 companies globally to secure a viscosupplementation MDR CE certificate. This accomplishment underscores Singclean Medical's technological expertise and international competitiveness in the field of orthopedic biomaterials and hyaluronic acid applications. 此次认证创造了多项行业纪录:这是DNV在全球范围内签发的首张透明质酸骨科类MDR CE证书;协合医疗为中国首家获此证书的企业,更成功跻身全球前三。这一成绩,充分彰显了协合医疗在骨科生物医用材料及透明质酸领域的技术积累与国际竞争力。 -
singclean | 2024-01-08
Singclean Medical’s 2nd International Aesthetic Medicine Leadership Summit Concludes Successfully in Shanghai Shanghai, August 27, 2026 – The 2nd International Aesthetic Medicine Leadership Summit, hosted by Singclean Medical, was held at W Shanghai – The Bund, within the IMCAS China Congress venue. Under the theme “Global Vision, Opening a New Chapter,” the summit served as a cross‑border, multi‑disciplinary platform for professional exchange, gathering an impressive lineup of leading physicians and global partners. -
singclean | 2024-01-08
Singclean Medical to Showcase Innovative Aesthetic and Medical Solutions at Dubai Derma 2026 and Medical Fair Asia 2026HANGZHOU, China – Hangzhou Singclean Medical Products Co., Ltd., a leading innovator in absorbable biomaterials and medical aesthetic solutions, has announced its participation in two major international exhibitions in September 2026: Dubai Derma 2026 in the United Arab Emirates and Medical Fair Asia 2026 in Singapore.